556 related articles for article (PubMed ID: 24174328)
1. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
2. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
[TBL] [Abstract][Full Text] [Related]
3. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Kumthekar P; Ko CH; Paunesku T; Dixit K; Sonabend AM; Bloch O; Tate M; Schwartz M; Zuckerman L; Lezon R; Lukas RV; Jovanovic B; McCortney K; Colman H; Chen S; Lai B; Antipova O; Deng J; Li L; Tommasini-Ghelfi S; Hurley LA; Unruh D; Sharma NV; Kandpal M; Kouri FM; Davuluri RV; Brat DJ; Muzzio M; Glass M; Vijayakumar V; Heidel J; Giles FJ; Adams AK; James CD; Woloschak GE; Horbinski C; Stegh AH
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692132
[TBL] [Abstract][Full Text] [Related]
4. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma.
Tommasini-Ghelfi S; Lee A; Mirkin CA; Stegh AH
Methods Mol Biol; 2019; 1974():371-391. PubMed ID: 31099015
[TBL] [Abstract][Full Text] [Related]
6. Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.
Sita TL; Kouri FM; Hurley LA; Merkel TJ; Chalastanis A; May JL; Ghelfi ST; Cole LE; Cayton TC; Barnaby SN; Sprangers AJ; Savalia N; James CD; Lee A; Mirkin CA; Stegh AH
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4129-4134. PubMed ID: 28373576
[TBL] [Abstract][Full Text] [Related]
7. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.
Stegh AH; Kim H; Bachoo RM; Forloney KL; Zhang J; Schulze H; Park K; Hannon GJ; Yuan J; Louis DN; DePinho RA; Chin L
Genes Dev; 2007 Jan; 21(1):98-111. PubMed ID: 17210792
[TBL] [Abstract][Full Text] [Related]
8. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
Stegh AH; Kesari S; Mahoney JE; Jenq HT; Forloney KL; Protopopov A; Louis DN; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10703-8. PubMed ID: 18669646
[TBL] [Abstract][Full Text] [Related]
9. What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator.
Stegh AH; Chin L; Louis DN; DePinho RA
Cell Cycle; 2008 Sep; 7(18):2833-9. PubMed ID: 18769159
[TBL] [Abstract][Full Text] [Related]
10. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES
Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
12. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
13. Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.
Stegh AH; DePinho RA
Cell Cycle; 2011 Jan; 10(1):33-8. PubMed ID: 21200141
[TBL] [Abstract][Full Text] [Related]
14. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Kouri FM; Ritner C; Stegh AH
Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
[TBL] [Abstract][Full Text] [Related]
15. GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.
Chou CH; Chou AK; Lin CC; Chen WJ; Wei CC; Yang MC; Hsu CM; Lung FW; Loh JK; Howng SL; Hong YR
Cell Cycle; 2012 Feb; 11(3):532-42. PubMed ID: 22262180
[TBL] [Abstract][Full Text] [Related]
16. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
17. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
Day BW; Stringer BW; Spanevello MD; Charmsaz S; Jamieson PR; Ensbey KS; Carter JC; Cox JM; Ellis VJ; Brown CL; Walker DG; Inglis PL; Allan S; Reynolds BA; Lickliter JD; Boyd AW
Neuro Oncol; 2011 Nov; 13(11):1202-12. PubMed ID: 21846680
[TBL] [Abstract][Full Text] [Related]
18. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
19. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
Kapadia CH; Melamed JR; Day ES
BioDrugs; 2018 Aug; 32(4):297-309. PubMed ID: 29959665
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]